# Genomic Opioid Optimization of Dosing and Selections (GOODS) Study

> **NCT03579121** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 76 (actual)

## Conditions studied

- Perioperative/Postoperative Complications

## Interventions

- **OTHER:** Pharmacogenomic (PGx)
- **OTHER:** Review results

## Key facts

- **NCT ID:** NCT03579121
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-12
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-04-01
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2022-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03579121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03579121, "Genomic Opioid Optimization of Dosing and Selections (GOODS) Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03579121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*